Difference between revisions of "Part:BBa K1993012"
Line 25: | Line 25: | ||
<html> | <html> | ||
− | <img src="https://static.igem.org/mediawiki/2016/ | + | <img src="https://static.igem.org/mediawiki/2016/c/c9/T--SYSU-MEDICINE--CCR2.jpg" style="width:150px" ></a> |
</html> | </html> | ||
Line 41: | Line 41: | ||
− | Then, we tested the chemotaxis of engineered MSCs by conducting Transwell assay against CCL2. To our excitement, our engineered MSCs had improved their homing ability with chemokine receptor CCR2(Figure | + | Then, we tested the chemotaxis of engineered MSCs by conducting Transwell assay against CCL2. To our excitement, our engineered MSCs had improved their homing ability with chemokine receptor CCR2(Figure 5). |
− | '''Figure | + | <html> |
+ | <img src="https://static.igem.org/mediawiki/2016/9/93/T--SYSU-MEDICINE--CCL2-transwell.jpeg" style="width:400px" ></a> | ||
+ | |||
+ | </html> | ||
+ | |||
+ | '''Figure 5. transwell assay of CCR2.''' | ||
==References== | ==References== |
Revision as of 13:59, 16 October 2016
CCR2
Chemokine receptors are receptors found on the surface of certain cells that interact with chemokines. They have a 7-transmembrane (7-TM) structure and couple to G-protein for signal transduction within a cell. [1] (Figure 1) Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux intracellular calcium (Ca2+) ions, initiate chemotaxis and guide the cell to a desired location. (Figure 2)
Figure 1. typical structure of a chemokine receptor.
Figure 2. the mechanism of interaction between chemokine and chemokine receptor.
Under the circumstances of inflammation, various kinds of cytokines, including chemokines, are released by the lesions. Guided by the chemokines, cells expressing chemokine receptors move towards the lesions where they can function better.[2] What’s more, different diseases would release different pools of chemokines, which would recruit different effector cells. See our disease table-chemokine
Based on the chemotaxis theory, in order to enhance the homing ability of our marvelous mesenchymal stem cells (MSCs) due to lack of enough chemokine receptors on their cell surface, we, SYSU-MEDICINE, had constructed a series of chemokine receptors that corresponding to different inflammatory diseases as far as possible. Among which, CCL2 is a significant chemokine (CCR2 is its chemokine receptor) in Cardiovascular disease(CVD) and Experimental Allergic Encephalomyelitis(EAE) . See our disease table-chemokine
We acquired this gene from peripheral mononuclear blood cells (PMBCs) and purified it. (Figure 3) Then we constructed it under the control of EF-1α by Gateway technology. (Figure 4)
Figure 3 purification of gene CCR2
Figure 4 Construction of expression vector of CCR2
Then, we tested the chemotaxis of engineered MSCs by conducting Transwell assay against CCL2. To our excitement, our engineered MSCs had improved their homing ability with chemokine receptor CCR2(Figure 5).
Figure 5. transwell assay of CCR2.
References
[1]Allen, Samantha J.; Crown, Susan E.; Handel, Tracy M. (2007-01-01). "Chemokine: receptor structure, interactions, and antagonism". Annual Review of Immunology. 25: 787–820.
[2] Griffith J W, Sokol C L, Luster A D. Chemokines and chemokine receptors: positioning cells for host defense and immunity.[J]. Annual Review of Immunology, 2014, 32(1):659-702. Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 1011